$AHG

Akso Health Group

CIK:0001702318|SEC Filings

Consolidated Statements of Operations and Comprehensive Loss - USD ($)	12 Months Ended
	Mar. 31, 2026	Mar. 31, 2025	Mar. 31, 2024
REVENUES
Net Revenues	$ 13,831,904	$ 14,777,798	$ 2,414,338
Cost of revenue	13,843,219	15,059,324	2,292,206
Gross Profit	(11,315)	(281,526)	122,132
OPERATING EXPENSE
Sales and marketing			168,421
General and administrative	3,988,741	3,641,446	8,591,751
Impairment of goodwill and intangible assets	16,700,276	162,381,380
Total Operating Expenses	20,689,017	166,022,826	8,760,172
LOSS FROM CONTINUING OPERATIONS	(20,700,332)	(166,304,352)	(8,638,040)
OTHER (EXPENSE) INCOME
Other income	344	47,091	252,408
Other expense	(4,729)	(12,992)	(114,168)
Exchange gain (loss)	272	(26)	(591,991)
Total Other (Expense) Income, net	(4,113)	34,073	(453,751)
LOSS FROM CONTINUING OPERATIONS BEFORE INCOME TAXES	(20,704,445)	(166,270,279)	(9,091,791)
(BENEFIT) PROVISON FOR INCOME TAXES	(1,988,264)	(30,801,146)	24,988
NET LOSS FROM CONTINUING OPERATIONS	(18,716,181)	(135,469,133)	(9,116,779)
Net loss from discontinued operations, net of income taxes			(3,884)
Loss from disposal of discontinued operations, net of income taxes			(395,914)
Total loss from discontinued operations			(399,798)
NET LOSS	(18,716,181)	(135,469,133)	(9,516,577)
Less: net loss attributable to non-controlling interest	(44,571)	(491,764)	(57,793)
NET LOSS ATTRIBUTABLE TO AKSO’S SHAREHOLDERS	(18,671,610)	(134,977,369)	(9,458,784)
OTHER COMPREHENSIVE LOSS
NET LOSS	(18,716,181)	(135,469,133)	(9,516,577)
Foreign currency translation adjustment	487,424	312,051	(238,594)
COMPREHENSIVE LOSS	(18,228,757)	(135,157,082)	(9,755,171)
Less: comprehensive loss attributable to non-controlling interest	(44,224)	(494,926)	(57,402)
COMPREHENSIVE LOSS ATTRIBUTABLE TO AKSO’S SHAREHOLDERS	$ (18,184,533)	$ (134,662,156)	$ (9,697,769)
Continuing operations
Basic (in Dollars per share)	$ 0.01	$ 0.16	$ 0.07
Diluted (in Dollars per share)	0.01	0.16	0.07
Discontinued operations
Basic (in Dollars per share)
Diluted (in Dollars per share)
Net (loss) per share
Basic (in Dollars per share)	0.01	0.16	0.07
Diluted (in Dollars per share)	$ 0.01	$ 0.16	$ 0.07
Weighted average shares
Basic (in Shares)	2,168,121,761	855,288,335	141,516,777
Diluted (in Shares)	2,168,121,761	855,288,335	141,516,777
Revenue
REVENUES
Revenue	$ 13,835,063	$ 14,781,622	$ 2,416,797
Tax and surcharges
REVENUES
Revenue	$ (3,159)	$ (3,824)	$ (2,459)

Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
Consolidated Statements of Cash Flows - USD ($)	Mar. 31, 2026	Mar. 31, 2025	Mar. 31, 2024
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss from continuing operations	$ (18,716,181)	$ (135,469,133)	$ (9,116,779)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Loss from disposal of discontinued operations			395,914
Provision for (recovery of) doubtful accounts	108,617	(100,000)	7,369,797
Goodwill impairment	11,069,876	41,366,680
Intangible assets impairment	5,630,400	121,114,699
Depreciation and amortization	2,371,615	2,149,790
Changes in the carrying amount of right-of-use assets	84,129	(98,947)
Deferred tax (benefit)	(1,990,055)	(30,804,128)
Accrued interests	527
Changes in operating assets and liabilities:
Accounts receivable	(435,482)	(859,542)	327,186
Prepayments and other assets	(5,420,639)	(6,440,314)	(130,770)
Inventories			1,495,248
Accounts payable, accrued expenses and other current liabilities	312,991	417,184	166,045
Operating lease liabilities	(56,605)	82,195
Contract liabilities	(5,809,914)	9,859,227	220,644
Taxes payable	59,421	(40,548)	(21,914)
Net cash (used in) provided by operating activities from continuing operations	(12,791,300)	1,177,163	705,371
Net cash provided by operating activities from discontinued operations			645,869
NET CASH (USED IN) PROVIDED BY OPERATING ACTIVITIES	(12,791,300)	1,177,163	1,351,240
CASH FLOWS FROM INVESTING ACTIVITIES:
Cash paid for loan originations		(35,525,131)
Acquisitions of property and equipment	(1,638)	(154,460)
Cash loans to third parties	(2,858,390)
Cash received from loan repayments	15,060,054	23,516,899	1,528,918
Cah paid in connection with acquisition		(93,750,000)	(56,250,000)
Prepayment for intangible assets development	(175,664,545)
Net cash (used in) investing activities from continuing operations	(163,464,519)	(105,912,692)	(54,721,082)
Net cash provided by investing activities from discontinued operations
NET CASH (USED IN) INVESTING ACTIVITIES	(163,464,519)	(105,912,692)	(54,721,082)
CASH FLOWS FROM FINANCING ACTIVITIES:
Repayments of loans due to related parties			(7,686,152)
Loan from third parties	350,000
Proceeds from private placement, net of offering costs		195,884,024	139,339,849
Net cash provided by financing activities from continuing operations	350,000	195,884,024	131,653,697
Net cash provided by financing activities from discontinued operations
NET CASH PROVIDED BY FINANCING ACTIVITIES	350,000	195,884,024	131,653,697
EFFECT OF EXCHANGE RATE CHANGE ON CASH	(153,483)	(1,123,015)	(1,272,164)
NET (DECREASE) INCREASE IN CASH	(176,059,302)	90,025,480	77,011,691
CASH AND CASH EQUIVALENTS – beginning of year	176,229,874	86,204,394	9,192,703
CASH AND CASH EQUIVALENTS – end of year	170,572	176,229,874	86,204,394
Less: cash and cash equivalents of discontinued operations at end of period			1,030,377
Cash and cash equivalents of continuing operations, at end of period	170,572	176,229,874	85,174,017
SUPPLEMENTAL CASH FLOW DISCLOSURES:
Cash paid for income tax	1,791	2,982	24,988
Cash paid for interest			111,563
Supplemental disclosure of non-cash information:
Right-of-use assets obtained in exchange for new lease liabilities		98,396
Modification of right-of-use assets and liabilities	$ (60,280)

Consolidated Balance Sheets - USD ($)	Mar. 31, 2026	Mar. 31, 2025
CURRENT ASSETS:
Cash and cash equivalents	$ 170,572	$ 176,229,874
Accounts receivable, net	1,281,065	954,200
Prepayments and other assets	12,229,837	6,809,198
Inventories	200,135	190,242
Loan receivables		11,941,378
Advances for capital expenditures	175,664,545
TOTAL CURRENT ASSETS	189,546,154	196,124,892
NON-CURRENT ASSETS
Property and equipment, net	12,015	16,148
Intangible assets, net	58,319	7,880,154
Right of use assets	16,897	98,396
Goodwill		10,833,735
TOTAL NON-CURRENT ASSETS	87,231	18,828,433
TOTAL ASSETS	189,633,385	214,953,325
CURRENT LIABILITIES:
Accrued expenses and other current liabilities	1,834,929	1,521,938
Contract liabilities	4,407,134	10,217,048
Taxes payable	93,284	33,863
Loan from third party	350,527
Operating lease liabilities-current	22,567	40,058
Amount due to related parties	2,000,000	2,000,000
TOTAL CURRENT LIABILITIES	8,708,441	13,812,907
NON-CURRENT LIABILITIES
Operating lease liabilities-non-current	2,565	41,679
Deferred tax liabilities		1,947,603
TOTAL NON-CURRENT LIABILITIES	2,565	1,989,282
TOTAL LIABILITIES	8,711,006	15,802,189
COMMITMENTS AND CONTINGENCIES (Note 24)
SHAREHOLDERS’ EQUITY:
Additional paid-in capital	405,525,513	405,616,966
Treasury stock (1,165,883 shares as of March 31, 2026 and 2025, respectively)	(3,988,370)	(3,988,370)
Accumulated deficit	(217,575,362)	(198,903,752)
Accumulated other comprehensive loss	(3,284,297)	(3,771,374)
TOTAL SHAREHOLDERS’ EQUITY	180,934,612	199,119,145
Non-controlling interest	(12,233)	31,991
TOTAL EQUITY	180,922,379	199,151,136
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY	189,633,385	214,953,325
Class A Ordinary Share
SHAREHOLDERS’ EQUITY:
Common stock value	256,330	164,877
Class B Ordinary Share
SHAREHOLDERS’ EQUITY:
Common stock value	$ 798	$ 798